Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Capell

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Agents and Actions. Supplements|January 1, 1988
MyocrisinH A Capell
British Journal of Rheumatology|November 1, 1995
Clinical efficacy of sulphasalazine--a reviewH A Capell
The Journal of Rheumatology|July 27, 2001
Effect of antimalarial agents on fasting lipid profile in systemic lupus erythematosusH A Capell
The Journal of Rheumatology. Supplement|June 21, 2001
Disease modifying antirheumatic drugs: longterm safety issuesH A Capell
British Journal of Rheumatology|October 1, 1988
Compliance revisitedH A Capell
The Practitioner|April 1, 1986
Rheumatoid arthritisH A Capell
Agents and Actions. Supplements|January 1, 1988
Design of trials to study variability in response: clinical aspects; end points in trialsH A Capell
Annals of the Rheumatic Diseases|February 1, 1985
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?T Pullar, H A Capell
Rheumatology (Oxford, England)|May 26, 1999
Corticosteroids in rheumatoid arthritis--the case againstE Morrison, H A Capell
Annals of the Rheumatic Diseases|September 25, 1999
Musculoskeletal disorders in the communityH A Capell, A Mcentegart
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Agents and Actions. Supplements|January 1, 1988
MyocrisinH A Capell
British Journal of Rheumatology|November 1, 1995
Clinical efficacy of sulphasalazine--a reviewH A Capell
The Journal of Rheumatology|July 27, 2001
Effect of antimalarial agents on fasting lipid profile in systemic lupus erythematosusH A Capell
The Journal of Rheumatology. Supplement|June 21, 2001
Disease modifying antirheumatic drugs: longterm safety issuesH A Capell
British Journal of Rheumatology|October 1, 1988
Compliance revisitedH A Capell
The Practitioner|April 1, 1986
Rheumatoid arthritisH A Capell
Agents and Actions. Supplements|January 1, 1988
Design of trials to study variability in response: clinical aspects; end points in trialsH A Capell
Annals of the Rheumatic Diseases|February 1, 1985
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question?T Pullar, H A Capell
Rheumatology (Oxford, England)|May 26, 1999
Corticosteroids in rheumatoid arthritis--the case againstE Morrison, H A Capell
Annals of the Rheumatic Diseases|September 25, 1999
Musculoskeletal disorders in the communityH A Capell, A Mcentegart
Pageof 17